Biochemical and molecular mechanisms for the association between obesity, chronic Inflammation, and breast cancer

BioFactors

Volumn 40, Issue 1, 2014, Pages 1-12

  Rose, David P ^a   Vona Davis, Linda ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipokines; Angiogenesis; Breast cancer; Cytokines; Inflammation; Obesity

Indexed keywords

ADIPOKINES; ANGIOGENESIS; BREAST CANCER; CYTOKINES; INFLAMMATION; OBESITY;

ANIMALS; BREAST NEOPLASMS; CHRONIC DISEASE; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; NEOVASCULARIZATION, PATHOLOGIC; OBESITY, ABDOMINAL;

EID: 84894079128     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1109     Document Type: Review

References (107)

1. American Cancer Society. (2012) Facts and Figures 2012. Atlanta. American Cancer Society.
2. Ferlay, J., Autier, P., Boniol, M., Heanue, M., Colombet, M., et al. (2007). Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 18, 581-592.
3. Ogden, C. L., Carroll, M. D., Kit, B. K., and Flegal, K. M. (2012). Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief 82, 1-8.
4. van den Brandt, P. A., Spiegelman, D., Yaun, S. S., Adami, H. O., Beeson, L., et al. (2000) Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am. J. Epidemiol. 152, 514-527.
5. Ursin, G., Longnecker, M. P., Haile, R. W., and Greenland, S. (1995) A meta-analysis of body mass index and risk of premenopausal breast cancer. Epidemiology 6, 137-141.
6. Peacock, S. L., White, E., Daling, J. R., Voigt, L. F., and Malone, K. E. (1999) Relation between obesity and breast cancer in young women. Am. J. Epidemiol. 149, 339-346.
7. Rose, D. P. and Vona-Davis, L. (2009) Influence of obesity on breast cancer receptor status and prognosis. Expert Rev. Anticancer Ther. 9, 1091-1101.
8. Shah, A., Mehta, N., and Reilly, M. P. (2008) Adipose inflammation, insulin resistance, and cardiovascular disease. JPEN J. Parenter. Enteral. Nutr. 32, 638-644.
9. Manabe, I. (2011) Chronic inflammation links cardiovascular, metabolic and renal diseases. Circ. J. 75, 2739-2748.
10. Karin, M. and Greten, F. R. (2005) NF-κB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5, 749-759.
11. Morris, P. G., Hudis, C. A., Giri, D., Morrow, M., Falcone, D. J., et al. (2011) Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev. Res. (Phila.). 4, 1021-1029.
12. Hursting, S. D. and Hursting, M. J. (2012) Growth signals, inflammation, and vascular perturbations: mechanistic links between obesity, metabolic syndrome, and cancer. Arterioscler. Thromb. Vasc. Biol. 32, 1766-1770.
13. Sun, X., Casbas-Hernandez, P., Bigelow, C., Makowski, L., Joseph Jerry, D., et al. (2012) Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression. Breast Cancer Res. Treat. 131, 1003-1012.
14. Harvie, M., Hooper, L., and Howell, A. H. (2003) Central obesity and breast cancer risk: a systematic review. Obes. Rev. 4, 157-173.
15. Rose, D. P., Komninou, D., and Stephenson, G. D. (2004) Obesity, adipocytokines, and insulin resistance in breast cancer. Obes. Rev. 5, 153-165.
16. Lorincz, A. M. and Sukumar, S. (2006) Molecular links between obesity and breast cancer. Endocr. Relat. Cancer. 13, 279-292.
17. Carmichael, A. R. (2006) Obesity and prognosis of breast cancer. Obes. Rev. 7, 333-340.
18. Rose, D. P., Haffner, S. M., and Baillargeon, J. (2007) Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr. Rev. 28, 763-777.
19. Rodriquez, A., Catalan, V., Gomez-Ambrosi, J., and Fruhbeck, G. (2007) Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome? Curr. Pharm. Des. 13, 2169-2175.
20. Alvehus, M., Buren, J., Sjostrom, M., Goedecke, J., and Olsson, T. (2010) The human visceral fat depot has a unique inflammatory profile. Obesity (Silver Springs) 18, 879-883.
21. Korsic, M., Gotovac, K., Nikolac, M., Dusek, T., Skegro, M., et al. (2012) Gene expression in visceral and subcutaneous adipose tissue in overweight women. Front Biosci. (Elite Ed.) 4, 2834-2844.
22. Subbaramaiah, K., Howe, L. R., Bhardwaj, P., Du, B., Gravaghi, C., et al. (2011) Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev. Res. (Phila). 4, 329-346.
23. Baglietto, L., English, D. R., Hopper, J. L., MacInnis, R. J., Morris, H. A., et al. (2009) Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition. Breast Cancer Res. Treat. 115, 171-179.
24. Key, T., Appleby, P., Barnes, I., and Reeves, G. (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J. Natl. Cancer Inst. 94, 606-616.
25. Bentzon, N., During, M., Rasmussen, B. B., Mouridsen, H., and Kroman, N. (2008) Prognostic effect of estrogen receptor status across age in primary breast cancer. Int. J. Cancer 122, 1089-1094.
26. O'Neill, J. S., Elton, R. A., and Miller, W. R. (1988) Aromatase activity in adipose tissue from breast quadrants: a link with tumour site. Br. Med. J. (Clin. Res. Ed.) 296, 741-743.
27. Bulun, S. E., Price, T. M., Aitken, J., Mahendroo, M. S., and Simpson, E. R. (1993) A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J. Clin. Endocrinol. Metab. 77. 1622-1628.
28. Zhao, Y., Nichols, J. E., Valdez, R., Mendelson, C. R., and Simpson, E. R. (1996) Tumor necrosis factor-α stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4. Mol. Endocrinol. 10, 1350-1357.
29. Catalano, S., Marsico, S., Giordano, C., Mauro, L., Rizza, P., et al. (2003) Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. J. Biol. Chem. 278, 28668-28676.
30. Jordan, V. C. and Brodie, A. M. (2007) Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer. Steroids 72, 7-25.
31. Sestak, I., Distler, W., Forbes, J. F., Dowsett, M., Howell, A., et al. (2010) Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial. J. Clin. Oncol. 28, 3411-3415.
32. Rinaldi, S., Key, T. J., Peeters, P. H., Lahmann, P. H., Lukanova, A., et al. (2006) Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort. Int. J. Cancer 118, 2832-2839.
33. Enger, S. M., Ross, R. K., Paganini-Hill, A., Carpenter, C. L., and Bernstein, L. (2000) Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol. Biomarkers Prev. 9, 681-687.
34. Rosenberg, L. U., Einarsdottir, K., Friman, E. I., Wedren, S., Dickman, P. W., et al. (2006) Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 15, 2482-2488.
35. Suzuki, R., Orsini, N., Saji, S., Key, T. J., and Wolk, A. (2009) Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status-a meta-analysis. Int. J. Cancer 124, 698-712.
36. Rose, D. P., Gilhooly, E. M., and Nixon, D. W. (2002) Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review). Int. J. Oncol. 21, 1285-1292.
37. Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., et al. (2012) Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations. J. Clin. Oncol. 30, 164-171.
38. Rose, D. P. and Vona-Davis, L. (2012) The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression. Endocr. Relat. Cancer 19, R225-R241.
39. Vona-Davis, L. and Rose, D. P. (2007) Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression. Endocr. Relat. Cancer 14, 189-206.
40. Fantuzzi, G. (2005) Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 115, 911-919.
41. Matarese, G., Moschos, S., and Mantzoros, C. S. (2005) Leptin in immunology. J. Immunol. 174, 3137-3142.
42. Garofalo, C. and Surmacz, E. (2006) Leptin and cancer. J. Cell Physiol. 207, 12-22.
43. Klein, S., Coppack, S. W., Mohamed-Ali, V., and Landt, M. (1996) Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 45, 984-987.
44. Catalano, S., Mauro, L., Marsico, S., Giordano, C., Rizza, P., et al. (2004) Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor α in MCF-7 cells. J. Biol. Chem. 279, 19908-19915.
45. Fusco, R., Galgani, M., Procaccini, C., Franco, R., Pirozzi, G., et al. (2010) Cellular and molecular crosstalk between leptin receptor and estrogen receptor-α in breast cancer: molecular basis for the novel therapeutic setting. Endocr. Relat. Cancer. 17, 373-382.
46. Ray, A., Nkhata, K. J., and Cleary, M. P. (2007) Effects of leptin on human breast cancer cell lines in relationship to estrogen receptor and HER2 status. Int. J. Oncol. 30, 1499-1509.
47. Otvos, L., Jr., Kovalszky, I., Riolfi, M., Ferla, R., Olah, J., et al. (2011) Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer. Eur. J. Cancer 47, 1578-1584.
48. McMurtry, V., Simeone, A. M., Nieves-Alicea, R., and Tari, A. M. (2009) Leptin utilizes Jun N-terminal kinases to stimulate the invasion of MCF-7 breast cancer cells. Clin. Exp. Metastasis 26, 197-204.
49. Kim, S. H., Nagalingam, A., Saxena, N. K., Singh, S. V., and Sharma, D. (2011) Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3. Carcinogenesis 32, 359-367.
50. Ishikawa, M., Kitayama, J., and Nagawa, H. (2004) Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin. Cancer Res. 10, 4325-4331.
51. Sethi, S., Sarkar, F. H., Ahmed, Q., Bandyopadhyay, S., Nahleh, Z. A., et al. (2011) Molecular markers of epithelial-to-mesenchymal transition are associated with tumor aggressiveness in breast carcinoma. Transl. Oncol. 4, 222-226.
52. Zhou, Y., Yau, C., Gray, J. W., Chew, K., Dairkee, S. H., et al. (2007) Enhanced NF κB and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer. BMC Cancer 7, 59.
53. Dent, R., Trudeau, M., Pritchard, K. I., Hanna, W. M., Kahn, H. K., et al. (2007) Triple-negative breast cancer: clinical features and patterns of recurrence. Clin. Cancer Res. 13, 4429-4434.
54. Subik, K., Lee, J. F., Baxter, L., Strzepek, T., Costello, D., et al. (2010) The expression patterns of ER, PR, HER-2, CK5/6, EGFR, Ki-67 and AR by immunohistochemical analysis in breast cancer cell lines. Breast Cancer (Auckl) 4, 35-41.
55. Liu, C. L., Chang, Y. C., Cheng, S. P., Chern, S. R., Yang, T. L., et al. (2007) The roles of serum leptin concentration and polymorphism in leptin receptor gene at codon 109 in breast cancer. Oncology 72, 75-81.
56. Vona-Davis, L., Rose, D. P., Hazard, H., Howard-McNatt, M., Adkins, F., et al. (2008) Triple-negative breast cancer and obesity in a rural Appalachian population. Cancer Epidemiol. Biomarkers Prev. 17, 3319-3324.
57. Kwan, M. L., Kushi, L. H., Weltzien, E., Maring, B., Kutner, S. E., et al. (2009) Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res. 11. R31.
58. Turkoz, F. P., Solak, M., Petekkaya, I., Keskin, O., Kertmen, N., et al. (2012) Association between common risk factors and molecular subtypes in breast cancer patients. Breast. pii. S0960-9776(12)00173-00177.
59. Wulster-Radcliffe, M. C., Ajuwon, K. M., Wang, J., Christian, J. A., and Spurlock, M. E. (2004) Adiponectin differentially regulates cytokines in porcine macrophages. Biochem. Biophys. Res. Commun. 316, 924-929.
60. Ajuwon, K. M. and Spurlock, M. E. (2005) Adiponectin inhibits LPS-induced NF-κB activation and IL-6 production and increases PPARγ2 expression in adipocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288, R1220-R1225.
61. Grossmann, M. E., Ray, A., Nkhata, K. J., Malakhov, D. A., Rogozina, O. P., et al. (2010) Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev. 29, 641-653.
62. Jarde, T., Perrier, S., Vasson, M. P., and Caldefie-Chezet, F. (2011) Molecular mechanisms of leptin and adiponectin in breast cancer. Eur. J. Cancer 47, 33-43.
63. Miyoshi, Y., Funahashi, T., Kihara, S., Taguchi, T., Tamaki, Y., et al. (2003) Association of serum adiponectin levels with breast cancer risk. Clin. Cancer Res. 9, 5699-5704.
64. Hou, W. K., Xu, Y. X., Yu, T., Zhang, L., Zhang, W. W., et al. (2007) Adipocytokines and breast cancer risk. Chin. Med. J. 120, 1592-1596.
65. Dieudonne, M. N., Bussiere, M., Dos Santos, E., Leneveu, M. C., Giudicelli, Y., et al. (2006) Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem. Biophys. Res. Commun. 345, 271-279.
66. Dos Santos, E., Benaitreau, D., Dieudonne, M. N., Leneveu, M. C., Serazin, V., et al. (2008) Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells. Oncol. Rep. 20, 971-977.
67. Taliaferro-Smith, L., Nagalingam, A., Zhong, D., Zhou, W., Saxena, N. K., et al. (2009) LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells. Oncogene 28, 2621-2633.
68. Wang, Y., Lam, J. B., Lam, K. S. L., Liu, J., Lam, M. C., et al. (2006) Adiponectin modulates the glycogen synthase kinase-3β/β-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res. 66, 11462-11470.
69. Howe, L. R. and Brown, AMC. (2004) Wnt signaling and breast cancer. Cancer Biol. Ther. 3, 36-41.
70. Clevers, H. and Nusse, R. (2012) Wnt/β-catenin signaling and disease. Cell 149, 1192-1205.
71. Li, Y., Hively, W. P., and Varmus, H. E. (2000) Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene 19, 1002-1009.
72. Christodoulides, C., Lagathu, C., Sethi, J. K., and Vidal-Puig, A. (2009) Adipogenesis and Wnt signalling. Trends Endocrinol. Metab. 20, 16-24.
73. Nunez, N. P., Perkins, S. N., Smith, N. C., Berrigan, D., Berendes, D. M., et al. (2008) Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones. Nutr. Cancer 60, 534-541.
74. Nogueira, L. M., Dunlap, S. M., Ford, N. A., and Hursting, S. D. (2012) Calorie restriction and rapamycin inhibit MMTV-Wnt-1 mammary tumor growth in a mouse model of postmenopausal obesity. Endocr. Relat. Cancer 19, 57-68.
75. Khramtsov, A. I., Khramtsoa, G. F., Tretiakova, M., Huo, D., Olopade, O. I., et al. (2010) Wnt/β-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am. J. Pathol. 176, 2911-2920.
76. Geyer, F. C., Lacroix-Triki, M., Savage, K., Arnedos, M., Lambros, M. B., et al. (2011) β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation. Mol. Pathol. 24, 209-231.
77. Zheng, Q., Dunlap, S. M., Zhu, J., Downs-Kelly, E., Rich, J., et al. (2011) Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival. Endocr. Relat. Cancer 18, 491-503.
78. Gliozzo, B., Sung, C. K., Scalia, P., Papa, V., Frasca, F., et al. (1998) Insulin-stimulated cell growth in insulin receptor substrate-1-deficient ZR-75-1 cells is mediated by a phosphatidylinositol-3-kinase-independent pathway. J. Cell Biochem. 70, 268-280.
79. Garofalo, C., Koda, M., Cascio, S., Sulkowska, M., Kanczuga-Koda, L., et al. (2006) Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin. Cancer Res. 12, 1447-1453.
80. Bartella, V., Cascio, S., Fiorio, E., Auriemma, A., Russo, A., et al. (2008) Insulin-dependent leptin expression in breast cancer cells. Cancer Res. 68, 4919-4927.
81. Sieri, S., Muti, P., Claudia, A., Berrino, F., Pala, V., et al. (2012) Prospective study on the role of glucose metabolism in breast cancer occurrence. Int. J. Cancer 130, 921-929.
82. Tong, Y., Lin, Y., Zhang, Y., Yang, J., Zhang, Y., et al. (2009) Association between TCFL2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med. Genet. 10, 15.
83. Naidu, R., Yip, C. H., and Taib, N. A. (2012) Genetic variations in transcription factor 7-like 2 (TCFL2) gene: association of TCFL2 rs12255372(G/T) or rs7903146(C/T) with breast cancer risk and clinic-pathological parameters. Med. Oncol. 29, 411-417.
84. Chocarro-Calvo, A., Garcia-Martinez, J. M., Ardila-Gonzalez, S., De la Vieja, A., and Garcia-Jimenez C. (2013) Glucose-induced β-catenin acetylation enhances Wnt signaling in cancer. Mol. Cell. 49, 474-486.
85. Lumeng, C. N., Bodzin, J. L., and Saltiel, A. R. (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175-184.
86. Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., et al. (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 46, 2347-2355.
87. Foroni, C., Broggini, M., Generali, D.: Damia, G. Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact. (2012) Cancer Treat. Rev. 38, 689-697.
88. Rose, D. P., Connolly, J. M., and Liu, X.-H. (1994) Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice and the invasive capacity of these cell lines in vitro. Cancer Res. 54, 6557-6562.
89. Yan, D., Avtanski, D., Saxena, N. K., and Sharma, D. (2012) Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways. J. Biol. Chem. 287, 8598-8612.
90. Morse-Gaudio, M., Connolly, J. M., and Rose, D. P. (1998) Protein kinase C and its isoforms in human breast cancer cells: relationship to the invasive phenotype. Int. J. Oncol. 12, 1349-1354.
91. Long, B. J. and Rose, D. P. (1996) Invasive capacity and regulation of urokinase-type plasminogen activator in estrogen receptor (ER)-negative MDA-MB-231 human breast cancer cells, and a transfectant (S30) stably expressing ER. Cancer Lett. 99, 209-215.
92. Sarrio, D., Rodriguez-Pinilla, S. M., Hardisson, D., Cano, A., Moreno-Bueno, G., et al. (2008) Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 68, 989-997.
93. Jeong, H., Ryu, Y. J., An, J., Lee, Y., and Kim, A. (2012) Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype. Histopathology 60, E87-95.
94. Tonetti, D. A., Gao, W., Escarzaga, D., Walters, K., Szafran, A., et al. (2012) PKCα and ERβ are associated with triple-negative breast cancers in African American and Caucasian patients. Int. J. Breast Cancer 2012, 740353.
95. Sullu, Y., Demirag, G. G., Yildirim, A., Karagoz, F., and Kandemir, B. (2011) Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast. Path. Res. Pract. 207, 747-753.
96. Gilbert, C. A. and Slingerland, J. M. (2013) Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. Annu. Rev. Med. 64:45-57.
97. Dunlap, S. M., Chiao, L. J., Nogueira, L., Usary, J., Perou, C. M., et al. (2012) Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models. Cancer Prev. Res. (Phila) 5, 930-942.
98. Price, R. S., Cavazos, D. A., De Angel, R. E., Hursting, S. D., and deGraffenried, L. A. (2012) Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells. Prostate Cancer Prostatic Dis. 15, 135-143.
99. Yang, Z., Norwood, K. A., Smith, J. E., Kerl, K. G., and Wood, J. R. (2012) Genes involved in the immediate early response and epithelial-mesenchymal transition are regulated by adipokines in the female reproductive tract. Mol. Reprod. Dev. 79, 128-137.
100. Vona-Davis, L. and Rose, D. P. (2009) Angiogenesis, adipokines and breast cancer. Cytokine Growth Factor Rev. 20, 193-201.
101. Christiaens, V. and Lijnen, H. R. (2010) Angiogenesis and development of adipose tissue. Mol. Cell Endocrinol. 318, 2-9.
102. Brakenhielm, E., Cao, R., Gao, B., Angelin, B., Cannon, B., et al. (2004) Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ. Res. 94, 1579-1588.
103. Gonzalez, R. R., Cherfils, S., Escobar, M., Yoo, J. H., Carino, C., et al. (2006) Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2). J. Biol. Chem. 281, 26320-26328.
104. Gu, J. W., Young, E., Patterson, S. G., Makey, K. L., Wells, J., et al. (2011) Postmenopausal obesity promotes tumor angiogenesis and breast cancer progression in mice. Cancer Biol. Ther. 11, 910-917.
105. Yoshida, S., Ono, M., Shono, T., Izumi, H., Ishibashi, T., et al. (1997) Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor-α-dependent angiogenesis. Mol. Cell Biol. 17, 4015-4023.
106. Newman, A. C. and Hughes, C. C. (2012) Macrophages and angiogenesis: a role for Wnt signaling. Vasc. Cell 4. 13.
107. Lin, E. Y. and Pollard, J. W. (2007) Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res. 67, 5064-5066.